Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

Termpanit Chalermpalanupap , Becky Kinkead , William T Hu , Markus P Kummer , Thea Hammerschmidt , Michael T Heneka , David Weinshenker and Allan I Levey

Alzheimer's Research & Therapy 2013, 5:21 (29 April 2013)

Treatments that increase norepinephrine transmission and may have the potential to delay or reverse Alzheimer's disease-related pathology are discussed by Levey and colleagues, who review the evidence for noradrenergic-based therapies.

Subscription required

All research articles in Alzheimer's Research & Therapy are open access. The journal also publishes a range of other articles that are available to subscribers.

Existing subscribers

Forgotten your password? help